Cytori Therapeutics, Inc. Q4 2008 Earnings Call Transcript

Sat, 21 Mar 2009 09:42:15 GMT

Cytori Therapeutics, Inc. (CYTX)Q4 2008 Earnings Call TranscriptMarch 6, 2009 10:30 am ETComplete Story

FDA panel pans Acusphere heart-imaging drug (AP)

Thu, 11 Dec 2008 00:06:46 GMT

FDA panel pans Acusphere heart-imaging drug. - WASHINGTON (AP) -- Federal advisers said Wednesday the risks of an imaging drug made by Acusphere, including abnormally low blood pressure, outweigh any advantages it has over older products.

Biotech Stocks: Drug stocks mixed; Amylin, Alkermes tumble (at Ma...

Tue, 04 Nov 2008 15:32:00 GMT

Drug stocks were mixed in early trading Tuesday, while shares of partners Amylin Pharmaceuticals and Alkermes Inc. tumbled on news that U.S. regulatory approval for their diabetes drug exenatide LAR could be delayed due to filing problems.

Cephalon reports profit spike on charges, raises outlook (at Mark...

Tue, 28 Oct 2008 20:36:59 GMT

BOSTON (MarketWatch) -- Cephalon Inc. late Tuesday reported net income of $112 million, or $1.42 a share, compared with a loss of $307 million, or $4.58 a share, for the same period last year. The 2007 quarter included hefty charges related to a settlement reserve fund. Excluding various accounting

Wyeth Earnings Dip Slightly (at TheStreet.com)

Wed, 22 Oct 2008 11:55:25 GMT

The drug developer's adjusted third-quarter earnings were in line with the estimates of analysts.. Check out TheStreet for the latest stock market news and financial investment headlines.

Symmetry Medical names new chief accounting officer

Wed, 27 Aug 2008 13:03:00 GMT

Symmetry Medical, a provider of implants and related instruments to the orthopedic device industry, has appointed Ronda Harris as its new chief accounting officer, effective September 1, 2008.

SonoSite And GE Resolve First Lawsuit

Thu, 31 Jul 2008 22:00:15 GMT

BOTHELL, WA - July 31, 2008 - SonoSite, Inc. (Nasdaq:SONO), the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced that the lawsuit General Electric Company (GE) filed against the company in federal district court in Madison, Wisconsin has been resolved

Bolivia's Aranjuez Thermal Plant to Add Two More General Electric...

Thu, 19 Jun 2008 01:04:24 GMT

CORDOBA, ARGENTINA--June 6, 2008--Researched by Industrial Info Resources (Sugar Land, Texas)--The Aranjuez thermal plant, owned and operated by Empresa Electrica Guaracachi S.A. (Santa Cruz, Bolivia), has recently added a 2-megawatt (MW) General Electric (NYSE:GE) (Fairfield, Connecticut) JNS 616

Springtime for Pharma: A Big Week Ahead For Earnings (at CNBC)

Fri, 18 Apr 2008 16:01:31 GMT

The irreverent producers of "Squawk on the Street" who are stationed in the pod next to mine here at CNBC like to call it "Pharmapalooza." They're referring to weeks like the one coming up when nearly every big drug company reports earnings.

GE Healthcare Launches Sterile Genderless Connector for Disposabl...

Thu, 27 Mar 2008 13:52:55 GMT

PHILADELPHIA, PA, MARCH 23, 2008 - GE Healthcare, a unit of General Electric (NYSE: GE), today launched of a range of sterile genderless connectors as part of its ReadyToProcess™ portfolio of ready-to-use bioprocessing systems.

Exergen And General Electric Healthcare Announce Partnership

Sat, 19 Jan 2008 18:32:17 GMT

PR: Exergen Corporation and GE Healthcare, a unit of General Electric Company, have recently entered into an agreement for non-exclusive global distribution of Exergen's model TAT-5000, the professional version of Exergen's award winning TemporalScanner™ Temporal Artery Thermometer. Con

Virtual House Calls -- Cigna HealthCare and RelayHealth plan to o...

Mon, 24 Apr 2006 18:03:33 GMT

Pharmacy Choice - Pharmaceutical News - Virtual House Calls -- Cigna HealthCare and RelayHealth plan to offer a Web-based system to let patients schedule appointments, view lab results, and get drug refills - May 3, 2006. Information Week via NewsEdge...

AGFA.com - Agfa-Gevaert to disinvest its Non-Destructive Testing ...

Agfa-Gevaert announces that it will disinvest its business group Non-Destructive Testing to GE Aircraft Engines, a division of General Electric Company (USA). The transaction will be completed upon receipt of regulatory approvals.

Healthcare IT News

General Electric has streamlined its unit structure from six units to four units. In the process, GE Healthcare is no longer a standalone unit, but will be included into the new GE Technology Infrastructure unit.

Personnel - Iomai promotes Jin-Sook Chung to vice president of hu...

January 10th, 2007 Iomai Corp. (IOMI) announced the promotion of Jin-Sook Chung to vice president of human resources from director of human resources and administration.

Quigley : News & Events :

DOYLESTOWN, PA (February, 10, 2006) The Quigley Corporation (NASDAQ: QGLY), announced today that it has partnered with Universal Pictures for a Cold-Eeze promotion tied to Curious George, the new film featuring the voices of Will Ferrell and Drew Barrymore that opens February 10th.

FDA cites safety concerns with Acusphere drug (AP)

Mon, 08 Dec 2008 16:52:59 GMT

FDA cites safety concerns with Acusphere drug. - WASHINGTON (AP) -- Shares of Acusphere plummeted Monday after federal regulators raised serious safety concerns about an imaging drug the company has touted as a potential blockbuster product.

Bristol-Myers' Collaboration with Exelixis Is Looking Lucrative

Mon, 24 Nov 2008 15:22:59 GMT

Eben Tessari submits:Exelixis announced that Bristol-Myers Squibb (BMY) has exercised its option to develop and commercialize Exelixis investigational new drug ((IND)) candidate XL413, a selective inhibitor of Cdc7. XL413

Nektar Therapeutics Q3 2008 Earnings Call Transcript (at Seeking ...

Thu, 20 Nov 2008 09:37:10 GMT

Good afternoon and thank you for joining us for the Nektar Therapeutics conference call. My name is Madge [ph], and I will be your coordinator for today. At this time, all participants are in a listen-only mode. We will be conducting a question-and-answer session toward the end of this conference.

WSJ: Wyeth to curb research on women's health drugs (at MarketWat...

Tue, 28 Oct 2008 17:35:47 GMT

BOSTON (MarketWatch) -- Wyeth plans to curb research on such women's health products as hormone replacement therapies and contraceptives, the Wall Street Journal reported Tuesday. Researchers told the newspaper that instead, Wyeth's research and development efforts will focus on such severe

Novartis to buy Nektar's pulmonary unit for $115M in cash (at Mar...

Tue, 21 Oct 2008 06:21:03 GMT

LONDO (MarketWatch) -- Swiss drug giant Novartis on Tuesday said it will buy the pulmonary business unit of Nektar Therapeutics for $115 million in cash. The unit develops medecines that can be delivered via the lungs. The transaction, however, excludes Nektar's inhalation programs for insulin,

Novartis reports progress with a cancer treatment (at MarketWatch...

Mon, 19 May 2008 05:45:41 GMT

TEL AVIV (MarketWatch) -- Novartis AG, the Basel pharmaceutical giant, reported progress in an interim trial of the drug RAD001 with advanced-kidney-cancer patients whose treatments with certain major therapies have failed. The findings showed that RAD001 extended the time without tumor growth from

AVANIR Pharmaceuticals Wall Street Analyst Forum Presentation Tra...

Wed, 10 Sep 2008 19:43:12 GMT

Good morning ladies and gentlemen. In our ongoing attempt to adhere to the public schedule, I would like to introduce the next company in this morning's Biotech and Specialty Pharmaceutical program.

Medtronic Accuses NuVasive of Patent Infringement

Wed, 20 Aug 2008 22:07:53 GMT

Douglas Cress submits:Device giant Medtronic (MDT) Sofamor Danek has filed a complaint against NuVasive (NUVA), alleging patent infringement by certain NuVasive products. NuVasive is in the process of reviewing the complaint

Genentech's Avasitin Price Is Unsustainable

Mon, 07 Jul 2008 06:24:39 GMT

Michael Steinberg submits:The New York Times Costly Cancer Drug Offers Hope, but Also a Dilemma examines the

Zibb.com: General Electric Company (Industry News & Blogs)